Coloplast A/S (0QBO)
London Exchange · UK · prices in DKK · close of 20 Oct 2026
Key indicators
| Last close | DKK 476.50 |
|---|---|
| 52-week range | 369.75 – 602.19 |
| Return, 1 month / 3 months | +14.1% / +15.1% |
| Return, 1 year / 3 years | −12.0% / −29.1% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -37.5% |
| Average daily value traded | 27.06M DKK |
| Dividend yield | 4.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Coloplast A/S is a Danish medical device company that develops and makes products for people with intimate healthcare needs. Its range covers ostomy care, such as stoma bags and skin barriers, continence care including catheters and urine collection products, and wound and skin care. It also supplies surgical and wound-healing devices. The company serves hospitals, clinics and home users through healthcare professionals and distributors in many countries, and it is based in Denmark.
The shares are listed on the London Exchange in UK under the code 0QBO, and the price on this page is in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Coloplast A/S (0QBO) trades on the London Exchange in UK. It last closed at DKK 476.50 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,193 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.0% and over the last three months it rose 15.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.3% | ||
| From 52-week high | -20.3% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.1% | ||
| 6-month return | 10.5% | ||
| 12-month return, skipping the last month | -22.8% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.5% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 27.06M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.8% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.5% |
|---|---|
| 1 month | +14.1% |
| 3 months | +15.1% |
| 6 months | +10.5% |
| 1 year | −12.0% |
| 3 years | −29.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 438.16 / 440.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | DKK 5.0000 |
| 5 Dec 2025 | DKK 18.0000 |
| 8 May 2025 | DKK 5.0000 |
| 6 Dec 2024 | DKK 17.0000 |
| 13 May 2024 | DKK 5.0000 |
| 8 Dec 2023 | DKK 16.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.